Barrett, P. Hugh R.
University of Helsinki · The University of Western Australia · Royal Perth Hospital · Helsinki University Hospital · Sahlgrenska University Hospital · University of Gothenburg
15 papers on CoChatORCID 0000-0003-3223-6125
Most cited papers
- Verified
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
Ooi, E. M. M., Barrett, P. H. R., Chan, D. C., & Watts, G. F. (2008) · Clinical Science
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 282
- Verified
Lipid disorders and mutations in the APOB gene
Whitfield, A. J., Barrett, P. H. R., van Bockxmeer, F. M., & Burnett, J. R. (2004) · Clinical Chemistry
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 243
- Verified
Differential Regulation of Lipoprotein Kinetics by Atorvastatin and Fenofibrate in Subjects With the Metabolic Syndrome
Watts, G. F., Barrett, P. H. R., Ji, J., Serone, A. P., Chan, D. C., Croft, K. D., Loehrer, F., & Johnson, A. G. (2003) · Diabetes
Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism
Cited by 219
- Verified
Randomized controlled trial of the effect of n–3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity
Chan, D. C., Watts, G. F., Mori, T. A., Barrett, P. H. R., Redgrave, T. G., & Beilin, L. J. (2003) · The American Journal of Clinical Nutrition
Fatty Acid Research and HealthLipid metabolism and disorders
Cited by 185
- Verified
Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia
Chan, D. C., Watts, G. F., Barrett, P. H. R., Beilin, L. J., Redgrave, T. G., & Mori, T. A. (2002) · Diabetes
Lipoproteins and Cardiovascular HealthLipid metabolism and disorders
Cited by 160
- Verified
Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity
Chan, D. C., Watts, G. F., Barrett, P. H., Mamo, J. C., & Redgrave, T. G. (2002) · Clinical Chemistry
Lipid metabolism and disordersDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 117
- Verified
ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan
Olin-Lewis, K., Krauss, R. M., La Belle, M., Blanche, P. J., Barrett, P. H. R., Wight, T. N., & Chait, A. (2002) · Journal of Lipid Research
Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism
Cited by 114
- Verified
Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.
Batal, R., Tremblay, M., Barrett, P. H. R., Jacques, H., Fredenrich, A., Mamer, O., Davignon, J., & Cohn, J. S. (2000) · Journal of Lipid Research
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 113
- Verified
Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes
Davis, Daly, Walsh, Ilett, Beilby, Dusci, L. J., & Barrett, P. H. R. (2000) · British Journal of Clinical Pharmacology
Diabetes Treatment and ManagementPharmacogenetics and Drug Metabolism
Cited by 75
- Verified · note
Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic Study
Borén, J., Watts, G. F., Adiels, M., Söderlund, S., Chan, D. C., Hakkarainen, A., Lundbom, J., Lundbom, N., Matikainen, N., Kahri, J., et al. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology
Lipid metabolism and disordersDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 72
- Verified
Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
Chan, D. C., Watts, G. F., Nguyen, M. N., & Barrett, P. H. R. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 70
- Verified
Effect of weight loss on postprandial lipemia and low-density lipoprotein receptor binding in overweight men
James, A. P., Watts, G. F., Barrett, P. H. R., Smith, D., Pal, S., Chan, D. C., & Mamo, J. C. L. (2003) · Metabolism
Lipid metabolism and disordersDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 54
- Verified
Effect of ω-3 Fatty Acid Ethyl Esters on Apolipoprotein B-48 Kinetics in Obese Subjects on a Weight-Loss Diet: A New Tracer Kinetic Study in the Postprandial State
Wong, A. T. Y., Chan, D. C., Barrett, P. H. R., Adams, L. A., & Watts, G. F. (2014) · The Journal of Clinical Endocrinology & Metabolism
Fatty Acid Research and HealthLipid metabolism and disorders
Cited by 30
- Verified
Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia
Cohn, J. S., Tremblay, M., Batal, R., Jacques, H., Veilleux, L., Rodriguez, C., Barrett, P. H. R., Dubreuil, D., Roy, M., Bernier, L., et al. (2002) · Journal of Lipid Research
Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism
Cited by 27
- Verified
Supplementation with n3 fatty acid ethyl esters increases large and small artery elasticity in obese adults on a weight loss diet
Wong, A. T. Y., Chan, D. C., Barrett, P. H. R., Adams, L. A., & Watts, G. F. (2013) · The Journal of Nutrition
Cardiovascular Health and Disease PreventionFatty Acid Research and Health
Cited by 23
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free